Huntington Memorial Hospital

Pasadena, California 91109-7013

10 studies enrolling now · 63 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Acute Pain, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anemia

Studies at this site

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer — Recruiting now
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer — Recruiting now
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer — Recruiting now
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab — Recruiting now
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas — Recruiting now
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab — Recruiting now
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 — Recruiting now
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER — Recruiting now
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) — Recruiting now
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer — Recruiting now
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
Trial of Latex Vs Non-latex Hemorrhoid Banding — Recruiting now
The PEERLESS II Study — Running, not enrolling
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial — Paused
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer — Running, not enrolling
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy — Running, not enrolling
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial — Running, not enrolling
Aveir DR i2i Study — Completed
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System — Completed
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts — Running, not enrolling
Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial — Running, not enrolling
The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy — Completed
Breast Cancer WEight Loss Study (BWEL Study) — Running, not enrolling
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain — Completed
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery — Running, not enrolling
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy — Stopped early
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy — Completed
XIENCE 28 USA Study — Completed
Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP) — Completed
Junctional AV Ablation in CRT-D: JAVA-CRT — Completed
Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair — Completed
ENABLE MRI (Magnetic Resonance Imaging) — Completed
Cardiovascular Inflammation Reduction Trial — Completed
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Stopped early
Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Completed
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
Ranolazine Implantable Cardioverter-Defibrillator Trial — Completed
Loop Band Validation Study — Completed
Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures — Completed
AngelMed for Early Recognition and Treatment of STEMI — Completed
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) — Completed
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer — Completed
Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy — Completed
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity — Status unconfirmed
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery — Completed
Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients — Completed